Industry Background:
Acyclovir Injection is used to treat acyclovir that is caused by the herpes simplex virus. This injection is used to treat first-time or repeat outbreaks of herpes simplex and to treat herpes zoster in people with weak immune systems. It is used in treating HIV, hepatitis, herpes simplex virus, influenza, and other diseases. It is also used to treat herpes simplex encephalitis (brain infection with swelling caused by the herpes virus) and herpes infections in newborn infants. Acyclovir injection is in a class of antiviral medications called synthetic nucleoside analogues. It works by stopping the spread of the herpes virus in the body.This growth is primarily driven by Increase In Population Growth And Prevalence Of Viral Diseases, Development Of Nanotechnology To Develop Antiviral Medication and Increasing Demand from Hospitals & Clinics in Emerging Countries.
Globally, a noticeable market trend is evident Technological Advancements In The Development Of Antiviral Medication. The Pharmaceuticals sector in the North America region has been increasing at a strong rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Zydus Pharmaceuticals (United States), Fresenius Kabi (Canada), Cipla Limited (India), Cadila Pharmaceuticals (India), Geo Pharma Pvt Ltd (India), SteriMax Inc. (Canada), GlaxoSmithKline plc (Germany), Pfizer (United States), AuroMedics Pharma LLC (United States), Hikma Pharmaceuticals (United Kingdom), Square Pharmaceuticals (Bangladesh), Sichuan KELUN PHARMACEUTICAL Co., Ltd. (China) and Shandong Qidu Pharmaceutical Co.,Ltd (China) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Regulatory Insights:
In Apr 2019, the Food and Drug Administration (FDA) approved a new drug application for Avaclyr. Acyclovir is the gold standard treatment in herpes virus infection, it provides therapy inform of the ophthalmic dosage form.
Market Drivers
- Increase In Population Growth And Prevalence Of Viral Diseases
- Development Of Nanotechnology To Develop Antiviral Medication
- Increasing Demand from Hospitals & Clinics in Emerging Countries
Market Trend
- Technological Advancements In The Development Of Antiviral Medication
Restraints
- Stringent Regulatory Approvals Of Acyclovir Injections
Opportunities
Growling Need For Broad Spectrum Drug, Increasing HIV Cases Globally and Rising Number of Skin Infection Diseases Especially With Pregnant Women
Challenges
May Cause Side Effects Such As nausea, vomiting, diarrhea, etc.
AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization of the Report:
AMA Research & Media features not only specific market forecasts, but also include significant value-added commentary on:
Market Trends
Technological Trends and Innovations
Regulatory Trends & Policies
Market Maturity Indicators
Market Share Movements
Growth Drivers and Constraints
New Entrants into the Market & Entry/Exit Barriers
Consumer Demographics
Supporting Company Financial and Cash Flow Planning
Open Up New Markets
To Seize Powerful Market Opportunities
Key Decision in Planning and to Further Expand Market Share
Identify Key Business Segments, Market Proposition & Gap Analysis